Glenmark Specialty S.A. partners with Lotus to commercialise Ryaltris in key Asian markets
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The acquisition would enable addition of established brands with high recall amongst healthcare professionals, especially in the vitamins, minerals and supplements category
ICICI Direct gives a preview on the earnings narrative for Q3FY22
Ind-Ra expects revenue growth of over 12% in 2022.
Dronedarone tablets USP, 400 mg have an estimated market size of US $ 500 million for twelve months ending September 2021 according to IQVIA
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Entacapone tablets USP, 200 mg have an estimated market size of US$ 10.5 million for twelve months ending September 2021, according to IQVIA
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Subscribe To Our Newsletter & Stay Updated